Update on perioperative bridging in patients on chronic oral anticoagulation

References

• Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation97, 1231–1233 (1998).
   PubMed Web of Science ®Google Scholar
• American Heart Association. 2002 Heart and Stroke Statistical Update. American Heart Association, TX, USA (2001).
   Google Scholar
• Spyropoulos AC, Bauersachs RM, Omran H, Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr. Med. Res. Opin.22, 1109–1122 (2006).
   PubMed Web of Science ®Google Scholar
• Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch. Intern. Med.163, 901–908 (2003).
   PubMed Web of Science ®Google Scholar
• Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J. Thromb. Haemost.5, 2211–2218 (2007).
   PubMed Web of Science ®Google Scholar
• Douketis JD, Crowther MA, Cherian SS. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Can. J. Cardiol.16, 326–330 (2000).
   PubMed Web of Science ®Google Scholar
• Douketis JD, Crowther MA, Cherian SS, Kearon CB. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest116, 1240–1246 (1999).
   PubMed Web of Science ®Google Scholar
• Douketis JD, Berger PB, Dunn AS et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest133, S299–S339 (2008).
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC. Bridging of oral anticoagulation therapy for invasive procedures Curr. Hematol. Rep.4, 405–413 (2005).
   PubMedGoogle Scholar
• Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb. Res.108, 3–13 (2002).
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Turpie AG. Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Curr. Opin. Pulm. Med.11, 373–379 (2005).
   PubMed Web of Science ®Google Scholar
• Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature. Surg. Laparosc. Endosc.7, 324–331 (1997).
   PubMed Web of Science ®Google Scholar
• Nutescu EA, Shorr AF, Farrelly E, Horblyuk R, Happe LE, Franklin M. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery. Ann. Pharmacother.42, 1216–1221 (2008).
   PubMed Web of Science ®Google Scholar
• Kearon C. Management of anticoagulation in patients who require invasive procedures. Semin. Vasc. Med.3, 285–294 (2003).
   PubMedGoogle Scholar
• Longstreth WT Jr, Bernick C, Fitzpatrick A et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology56, 368–375 (2001).
   PubMed Web of Science ®Google Scholar
• Durrleman N, Pellerin M, Bouchard D et al. Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute. J. Thorac. Cardiovasc. Surg.127, 1388–1392 (2004).
   PubMed Web of Science ®Google Scholar
• Rietbrock S, Heeley E, Plumb J, van Staa T. Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age >75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am. Heart J.156, 57–64 (2008).
   PubMed Web of Science ®Google Scholar
• Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA285, 2864–2870 (2001).
   PubMed Web of Science ®Google Scholar
• Zhu T, Martinez I, Emmerich J. Venous thromboembolism: risk factors for recurrence. Arterioscler. Thromb. Vasc. Biol.29, 298–310 (2009).
   PubMed Web of Science ®Google Scholar
• Dunn AS, Wisnivesky J, Ho W, Moore C, McGinn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision analysis. Med. Decis. Making25, 387–397 (2005).
   PubMed Web of Science ®Google Scholar
• White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann. Intern. Med.122, 40–42 (1995).
   PubMed Web of Science ®Google Scholar
• Palareti G, Legnani C. Warfarin withdrawal. Pharmacokinetic–pharmacodynamic considerations. Clin. Pharmacokinet.30, 300–313 (1996).
   PubMed Web of Science ®Google Scholar
• Katholi RE, Nolan SP, McGuire LB. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am. Heart J.96, 163–165 (1978).
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Turpie AG, Dunn AS et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J. Thromb. Haemost.4, 1246–1252 (2006).
   PubMed Web of Science ®Google Scholar
• Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ. Cost analysis of “bridging therapy” with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am. J. Cardiol.93, 509–511 (2004).
   PubMed Web of Science ®Google Scholar
• Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am. J. Cardiol.93, 247–250 (2004).
   PubMed Web of Science ®Google Scholar
• Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch. Intern. Med.164, 1319–1326 (2004).
   PubMedGoogle Scholar
• Warkentin TE, Greinacher A, Koster A, Lincoff AM; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest133, S340–S380 (2008).
   PubMedGoogle Scholar
• Hammerstingl C, Omran H, Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures. Thromb. Haemost.101, 1085–1090 (2009).
   PubMed Web of Science ®Google Scholar
• Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126, S188–S203 (2004).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ. “Bridging” and mechanical heart valves: perils, promises, and predictions. Circulation113, 470–472 (2006).
   PubMed Web of Science ®Google Scholar
• Seshadri N, Goldhaber SZ, Elkayam U et al. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am. Heart J.150, 27–34 (2005).
   PubMed Web of Science ®Google Scholar
• White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch. Intern. Med.160, 2033–2041 (2000).
   PubMedGoogle Scholar
• Karmy-Jones R, Jurkovich GJ, Velmahos GC et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. J. Trauma62, 17–24; discussion 24–25 (2007).
   PubMedGoogle Scholar
• Ingber S, Geerts WH. Vena caval filters: current knowledge, uncertainties and practical approaches. Curr. Opin. Hematol.16(5), 402–406 (2009).
   PubMed Web of Science ®Google Scholar
• Kaufman JA, Rundback JH, Kee ST et al. Development of a research agenda for inferior vena cava filters: proceedings from a multidisciplinary research consensus panel. J. Vasc. Interv. Radiol.20, 697–707 (2009).
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Larson LR, Yamashita BD, Fain JM, Schumock GT. Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study. Am. J. Gastroenterol.96, 2360–2366 (2001).
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest125, 1642–1650 (2004).
   PubMed Web of Science ®Google Scholar
• Turpie AG. Direct Factor Xa and direct thrombin inhibitors: a clinical trial update. Curr. Opin. Drug Discov. Devel.12, 497–508 (2009).
   PubMedGoogle Scholar
• Eriksson BI, Quinlan DJ, Weitz JI. Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and Factor Xa inhibitors in development. Clin. Pharmacokinet.48, 1–22 (2009).
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med.361, 1139–1151 (2009).
   PubMed Web of Science ®Google Scholar